Document Detail

Ranolazine as a Promising Treatment Option for Atrial Fibrillation: Electrophysiologic Mechanisms, Experimental Evidence, and Clinical Implications.
MedLine Citation:
PMID:  25138058     Owner:  NLM     Status:  Publisher    
Currently available agents for pharmacologic management of atrial fibrillation (AF) are limited by their suboptimal efficacy and nonnegligible proarrhythmic risk. Ranolazine (RN) is a novel antianginal agent with increasingly appreciated antiarrhythmic properties that can suppress ventricular and supraventricular arrhythmias including AF. In this review, we describe the electrophysiological properties of RN, focusing on atrial-selective inhibition of a number of ion channels implicated in the development of AF, particularly the sodium current. We further summarize evidence from experimental studies that demonstrate a potent AF-suppressing effect of RN, alone or in combination with other antiarrhythmic drugs. Of clinical relevance, we present growing evidence from preliminary clinical investigations indicating the safety and efficacy of RN for prevention and treatment of AF in various clinical settings including prevention of AF in patients with acute coronary syndromes, prevention and conversion of postoperative AF after surgical coronary revascularization, sinus rhythm maintenance in drug-resistant recurrent AF, and facilitating of electrical or pharmacological cardioversion in cardioversion-resistant patients. While current experimental and clinical evidence points to RN as a potentially promising agent for suppression of AF, well-designed, large-scale trials will be required before RN can be considered for pharmacological treatment of AF in clinical practice.
Nikolaos Fragakis; Konstantinos C Koskinas; Vassilios Vassilikos
Related Documents :
15096458 - Thyrotropin-releasing hormone is induced in the left ventricle of rats with heart failu...
20930148 - Angiotensin-converting enzyme inhibition prevents the release of monocytes from their s...
11123228 - Myocardial remodeling and arrhythmogenesis in moderate cardiac hypertrophy in rats.
14980008 - Antihypertensive and anti-arrhythmic effects of an extract of radix stephaniae tetrandr...
9921958 - Magnetic field exposure and cardiovascular disease mortality among electric utility wor...
6686548 - Specificity of light and electron microscopic features of hypertrophic obstructive and ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-19
Journal Detail:
Title:  Pacing and clinical electrophysiology : PACE     Volume:  -     ISSN:  1540-8159     ISO Abbreviation:  Pacing Clin Electrophysiol     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7803944     Medline TA:  Pacing Clin Electrophysiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
©2014 Wiley Periodicals, Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B vir...
Next Document:  Adolescent chronic pain and association to perinatal factors: Linkage of Birth Registry data with th...